News | April 21, 2023
Top 20 global biopharma companies report 3.4% fall in market cap in Q1 2023: GlobalData
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
The company will set up a MRI, CT Scan, Sonography- Ultrasound, X-Ray Center and Pathology Lab
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Ministry of Ayush is leading a topic group on traditional medicine as part of Focus Group on Artificial Intelligence for Health (FG-AI4H)
Healthcare leaders are heavily investing in AI or plan to do so for both critical decision support and operational efficiency, helping tackle staff shortages
Several late-stage pipeline products have the potential to address some of these unmet needs
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
The Theme of the event was 'Building One Health Together – Improving Health Equity'
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
Subscribe To Our Newsletter & Stay Updated
